Gladstone NOW: The Campaign Join Us on the Journey✕
In honor of International Transgender Day of Visibility, Gladstone hosted three accomplished scientists to present their research and how it relates to better understanding the biology of gender and health disparities in the transgender community.
Luis Gutierrez-Mock, MPH, MA, is the project director for TRIUMPH, a community-led PrEP project at the Center of Excellence for Transgender Health at UC San Francisco. He previously worked on a CDC-funded project to promote knowledgeable, sensitive, and effective HIV/AIDS treatment and prevention services for trans communities.
Karissa Sanbonmatsu, PhD, is a principal investigator at Los Alamos National Laboratory. Her research investigates the molecular mechanisms by which epigenetic memories are written and stored in DNA and RNA, and how these relate to our understanding of social and environmental impacts on identity and development.
Charlotte Tate, PhD, is an associate professor of psychology at San Francisco State University. Her research investigates the constellation of psychological constructs and social experiences that count as “gender” in the United States, and how to better conceptualize, measure, and statistically model these experiences in basic behavioral science in ways that integrate cisgender and transgender spectrum lived experiences.
Our people are our most important asset. We offer a wide array of career opportunities both in our administrative offices and in our labs.
Explore CareersA new collaboration between Gladstone Institutes and Murdoch Children’s Research Institute to accelerate life-saving therapies for children affected by heart disease.
Institutional News Cardiovascular DiseaseGage has reshaped our understanding of stem cells in the adult brain with landmark discoveries that may contribute to the development of new or better therapies for neurological disorders.
Awards Institutional News News Release Ogawa Stem Cell Prize Stem Cells/iPSCsThe $350 million Gladstone NOW campaign will raise funds to expand Gladstone’s footprint, hire hundreds of additional scientists, and seize emerging opportunities for high-impact biomedical research that can overcome disease.
Philanthropy Institutional News News Release